| Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group … JP Donnelly, SC Chen, CA Kauffman, WJ Steinbach, JW Baddley, ... Clinical Infectious Diseases 71 (6), 1367-1376, 2020 | 1900 | 2020 |
| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group … OA Cornely, A Alastruey-Izquierdo, D Arenz, SCA Chen, E Dannaoui, ... The Lancet infectious diseases 19 (12), e405-e421, 2019 | 1426 | 2019 |
| Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline AJ Ullmann, JM Aguado, S Arikan-Akdagli, DW Denning, AH Groll, ... Clinical Microbiology and Infection 24, e1-e38, 2018 | 1284 | 2018 |
| Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007 A Skiada, L Pagano, A Groll, S Zimmerli, B Dupont, K Lagrou, C Lass-Florl, ... Clinical Microbiology and Infection 17 (12), 1859-1867, 2011 | 804 | 2011 |
| Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study AFAD Schauwvlieghe, BJA Rijnders, N Philips, R Verwijs, L Vanderbeke, ... The Lancet Respiratory Medicine 6 (10), 782-792, 2018 | 779 | 2018 |
| Galactomannan and computed tomography–based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study J Maertens, K Theunissen, G Verhoef, J Verschakelen, K Lagrou, ... Clinical Infectious Diseases 41 (9), 1242-1250, 2005 | 775 | 2005 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013 OA Cornely, S Arikan‐Akdagli, E Dannaoui, AH Groll, K Lagrou, ... Clinical Microbiology and Infection 20, 5-26, 2014 | 730 | 2014 |
| Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients … J Maertens, J Verhaegen, K Lagrou, J Van Eldere, M Boogaerts Blood, The Journal of the American Society of Hematology 97 (6), 1604-1610, 2001 | 730 | 2001 |
| Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients W Meersseman, K Lagrou, J Maertens, A Wilmer, G Hermans, ... American journal of respiratory and critical care medicine 177 (1), 27-34, 2008 | 605 | 2008 |
| ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others AM Tortorano, M Richardson, E Roilides, A Van Diepeningen, M Caira, ... Clinical Microbiology and Infection 20, 27-46, 2014 | 473 | 2014 |
| Invasive aspergillosis in the intensive care unit W Meersseman, K Lagrou, J Maertens, EV Wijngaerden Clinical infectious diseases 45 (2), 205-216, 2007 | 466 | 2007 |
| The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries M Hoenigl, D Seidel, A Carvalho, SM Rudramurthy, A Arastehfar, ... The Lancet Microbe 3 (7), e543-e552, 2022 | 369 | 2022 |
| Symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection by a phylogenetically distinct strain J Van Elslande, P Vermeersch, K Vandervoort, T Wawina-Bokalanga, ... Clinical Infectious Diseases 73 (2), 354-356, 2021 | 355 | 2021 |
| Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion PE Verweij, BJA Rijnders, RJM Brüggemann, E Azoulay, M Bassetti, ... Intensive care medicine 46 (8), 1524-1535, 2020 | 332 | 2020 |
| International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus PE Verweij, M Ananda-Rajah, D Andes, MC Arendrup, RJ Brüggemann, ... Drug Resistance Updates 21, 30-40, 2015 | 323 | 2015 |
| ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi A Chowdhary, JF Meis, J Guarro, GS De Hoog, S Kathuria, MC Arendrup, ... Clinical Microbiology and Infection 20, 47-75, 2014 | 318 | 2014 |
| Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb M Khan, SJ Yoo, M Clijsters, W Backaert, A Vanstapel, K Speleman, ... Cell 184 (24), 5932-5949. e15, 2021 | 293 | 2021 |
| Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases J Maertens, V Maertens, K Theunissen, W Meersseman, P Meersseman, ... Clinical infectious diseases 49 (11), 1688-1693, 2009 | 289 | 2009 |
| Diagnostic performance of seven rapid IgG/IgM antibody tests and the Euroimmun IgA/IgG ELISA in COVID-19 patients J Van Elslande, E Houben, M Depypere, A Brackenier, S Desmet, ... Clinical Microbiology and Infection 26 (8), 1082-1087, 2020 | 288 | 2020 |
| Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study J Wauters, I Baar, P Meersseman, W Meersseman, K Dams, R De Paep, ... Intensive care medicine 38, 1761-1768, 2012 | 276 | 2012 |
